- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03937700
Robot Based Gait Training Therapy for Pediatric Population With Cerebral Palsy Using the CPWalker
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objectives:
- To determine the use of the CPWalker rehabilitation platform, a robotic device composed by an exoskeleton linked to a walker that provides support and balance, as a gait training intervention in the pediatric cerebral palsy population.
- To create and define detailed guidelines consisting of robotic based treatment methods for gait rehabilitation.
Hypothesis:
- CPWalker can be used as a gait training intervention for pediatric patients with gait impairments due to cerebral palsy
- Performing lower limb training in conjunction with active head and trunk control therapies will improve functional gait levels
- Following 16-24 CPWalker training sessions, persons with cerebral palsy will show improvements in functional mobility when comparing pre-training measurements to post-training measurements
Procedures:
Participants will engage in an 8-week training program, consisting of 2-3 sessions per week based on the level of gait impairment. Percentage range of motion (ROM), partial body weight support (PWBS), and gait velocity are the principal parameters under variation during training.
Additionally, screening, baseline and post-training testing sessions will be conducted
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sara Prokup, DPT
- Phone Number: 312-238-1355
- Email: sprokup@ricres.org
Study Contact Backup
- Name: Matt McGuire, DPT
- Phone Number: 312-238-3457
- Email: mmcguire@ricres.org
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Shirley Ryan AbilityLab
-
Contact:
- Sara Prokup, DPT
- Phone Number: 312-238-1355
- Email: sprokup@ricres.org
-
Contact:
- Matt McGuire, DPT
- Phone Number: 312-238-3457
- Email: mmcguire@ricres.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of Cerebral Palsy with spastic diplegia
- Gross Motor Function Classification System score of 2-4
- Age 11-21 at time of enrollment
- Maximum weight of 75kg
- Height range of approximately 110cm to 170cm
- Ability to understand and follow verbal cues
- Lower limb measurements meet specifications of CPWalker
- Cognition sufficient to communicate pain or discomfort and follow one step direction from the investigator
Exclusion Criteria:
- Any orthopedic surgeries less than 3 months prior to study enrollment or ongoing botox injections
- Severe musculoskeletal deformities affecting safe and comfortable fit into the exoskeleton as determined by the investigator. Patients may be able to wear their AFOs in the CPWalker if it allows for safe fit.
- Unhealed wounds/lesions
- Critical motor control alterations such as dystonia, choreoathetosis, or ataxia
- Aggressive or self-harming behavior
- Severe cognitive impairments that prevent a subject from being able to understand the exercises an/or interact with the study staff
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CPWalker Robotic-Assisted Gait Training
Each subject will participate in 16-24 gait training sessions in the CPWalker over the course of 8 weeks with each session lasting up to 2 hours
|
The CPWalker rehabilitation platform is a robotic device composed by an exoskeleton linked to a walker that provides support and balance to a child during overground training.
The device is able to implement user's partial body weight support (PBWS) and allows the adaptation of exercises to the patient's capabilities by means of individual controllers for each joint, which increases the modularity of the system.
Each joint of the CPWalker can operate in a range of modes with varied levels of robotic assistance or resistance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
10-Meter Walk Test
Time Frame: Change from baseline gait speed at 8 weeks
|
This test will examine the patient's gait speed.
Patients will be directed to walk at their preferred and maximum but safe speed.
Patients will be positioned 1 meter before the start line and instructed to walk the entire 10-meter distance and past the end line approximately 1 meter.
The distance before and after the course are meant to minimize the effect of acceleration and deceleration.
Time will be recorded using a stopwatch and recorded to the one hundredth of a second.
|
Change from baseline gait speed at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6-Minute Walk Test
Time Frame: Change from baseline distance ambulated at 8 weeks
|
This test measures the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary.
The test is a reliable and valid evaluation of functional exercise capacity and is used as a sub-maximal test of aerobic capacity and endurance.
The test is patient self-paced and assesses the level of functional capacity.
Patients are allowed to stop and rest during the test, however, the timer does not stop.
If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded.
This test will be administered while wearing a mask to measure oxygen consumption.
|
Change from baseline distance ambulated at 8 weeks
|
GAITRite Data Collection
Time Frame: Change from baseline gait quality at 8 weeks
|
The GAITRite system automates measuring temporal and spatial gait parameters via an electronic walkway connected to a computer.
The GAITRite electronic walkway contains sensor pads encapsulated in a carpet to collect gait information.
The system can be laid over any flat surface.
The GAITRite electronic walkway for the study shall be a minimum of 14 feet long.
The GAITRite data capture was chosen as measurement of the patient's overall gait quality.
Patients will be asked to walk at a self-selected speed across the GAITRite electronic walkway with at least a two meter "flying start" to compensate for initial acceleration.
|
Change from baseline gait quality at 8 weeks
|
Pediatric Balance Scale
Time Frame: Change from baseline balance score at 8 weeks
|
This test is a 14-item objective measure designed to assess static balance in pediatric populations.
The functional activities that are assessed include sitting and standing balance during transfers, altered base of support, reaching, turning, eyes open and closed.
Each item is scored from 0 to 4 points.
The maximum score is 56 points.
|
Change from baseline balance score at 8 weeks
|
Selective Control Assessment of Lower Extremity (SCALE)
Time Frame: Change from baseline selective voluntary motor control at 8 weeks
|
This clinical tool quantifies selective voluntary motor control of the lower extremities in patients with cerebral palsy.
|
Change from baseline selective voluntary motor control at 8 weeks
|
Gross Motor Function Measure (GMFM-88) dimensions D (standing) and E (walking)
Time Frame: Change from baseline gross motor function at 8 weeks
|
This test measures the change in gross motor function with intervention in children with cerebral palsy
|
Change from baseline gross motor function at 8 weeks
|
Child and Adolescent Scale of Participation
Time Frame: Change in children's baseline participation in activities at 8 weeks
|
This questionnaire measures the extent to which children participate in home, school, and community activities as reported by family caregivers.
|
Change in children's baseline participation in activities at 8 weeks
|
Gillette Functional Assessment Questionnaire (FAQ)
Time Frame: Change in baseline report of ambulatory function at 8 weeks
|
This is a proxy-report measure that includes a ten-level classification of ambulatory function and 22 functional locomotor activities
|
Change in baseline report of ambulatory function at 8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00206310
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Gazi UniversityCompletedCerebral Palsy | Cerebral Palsy, Spastic | Cerebral Palsy Spastic Diplegia | Cerebral Palsy Quadriplegic | Cerebral Palsy, MonoplegicTurkey
-
Northwestern UniversityActive, not recruitingCerebral Palsy | Diplegic Cerebral Palsy | Bilateral Cerebral PalsyUnited States
-
Centre Médico-Chirurgical de Réadaptation des Massues...RecruitingCerebral Palsy, Dyskinetic | Cerebral Palsy, Spastic | Infantile Hemiplegic Cerebral PalsyFrance
-
St Mary's University CollegeUniversity of GloucestershireUnknownCerebral Palsy | Cerebral Palsy Ataxic | Cerebral Palsy, MixedUnited Kingdom
-
Hilde FeysHasselt University; ETH Zurich; Curtin UniversityRecruitingHemiplegic Cerebral Palsy | Cerebral Palsy, SpasticBelgium
-
University of California, San FranciscoNational Institutes of Health (NIH)RecruitingDystonic Cerebral Palsy | Dyskinetic Cerebral PalsyUnited States
-
East Carolina UniversityRecruitingHemiplegic Cerebral Palsy | Unilateral Cerebral Palsy | Remote Ischemic ConditioningUnited States
-
MTI UniversityEnrolling by invitationSpastic Diplegic Cerebral PalsyEgypt
-
October 6 UniversityCompletedSpastic Cerebral Palsy | Spastic Hemiplegic Cerebral PalsyEgypt
-
Marmara UniversityUnknownCerebral Palsy, Spastic | Cerebral Palsy, Spastic, DiplegicTurkey
Clinical Trials on CPWalker Robotic Exoskeleton
-
Stanford UniversityWithdrawnPrimary Knee Replacement SurgeryUnited States
-
National University Hospital, SingaporeTemasek Foundation CaresCompletedStroke | Spinal Cord Diseases | Spinal Cord InjuriesSingapore
-
VA Office of Research and DevelopmentSyracuse UniversityNot yet recruitingMovement Disorders | Spinal Cord Injury | SpasticityUnited States
-
Georgia Institute of TechnologyEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruiting
-
University of CalgaryQueen's UniversityRecruiting
-
Corporación de Rehabilitación Club de Leones Cruz...University of Valladolid; Universidad de MagallanesCompleted
-
College of St. Scholastica, Inc.Honda R and D Americas, Inc.CompletedStrokeUnited States
-
Kessler FoundationKessler Institute for RehabilitationRecruitingMultiple Sclerosis | Cognitive Impairment | Gait Disorders, Neurologic | Motility DisorderUnited States
-
Marmara UniversityRecruiting
-
Father Flanagan's Boys' HomeRecruiting